CD8A and neoplasm: An increased presence of CD8+ CD103+ tissue-resident tumor-infiltrating lymphocytes (TILs), a highly activated subpopulation of effector T cells primed to carry out cytolytic effector functions, is associated with enhanced survival in patients with lung cancer [39].